Potter J, Langhorne P, Roberts M
Victoria Geriatric Unit, Victoria Infirmary NHS Trust, Glasgow G41 3DX.
BMJ. 1998 Aug 22;317(7157):495-501. doi: 10.1136/bmj.317.7157.495.
To determine whether routine oral and enteral nutritional supplementation can improve the weight, anthropometry, and survival of adult patients.
Systematic review of randomised controlled trials of oral or enteral protein supplementation in adults. Trials were identified from Medline (Silver Platter 3.11, 1966-96), reference lists of identified studies and review articles, and communication with feed manufacturers.
Randomised controlled trials comparing oral or enteral protein supplementation with no routine supplementation. All trials of adult subjects were included except those addressing nutrition in pregnancy.
Change in body weight and anthropometry (mid-arm muscle circumference), and all cause case fatality recorded at the end of scheduled follow up. Body weight and anthropometry were analysed as the weighted mean difference and 95% confidence intervals of the percentage change in these variables. Case fatality was analysed with odds ratio and 95% confidence intervals.
32 eligible reports (2286 randomised patients) published between February 1979 and July 1996 were identified, of which 30 (93.8%) (2062 randomised patients) reported outcomes of interest. Case fatality data were available for 1670 (81%) patients, and continuous variable data for up to 1607 (78%) patients. The treatment group receiving routine nutritional supplementation showed consistently improved changes in body weight and anthropometry compared with controls; weighted mean difference 2.06% (95% confidence interval 1.63% to 2.49%) and 3.16% (2.43% to 3.89%) respectively. The pooled odds ratio for death in the treatment group was 0.66 (0.48 to 0.91, 2P<0.01). Apparent benefits were observed in several prespecified subgroups of patients, treatment settings, and interventions, but were not evident if trials with less robust methodology were excluded.
Routine oral or enteral supplementation seems to improve the nutritional indices of adult patients, but there are insufficient data in trials which meet strict methodological criteria to be certain if mortality is reduced. Benefits were not restricted to particular patient groups. Further large pragmatic randomised controlled trials of routine nutritional supplementation are justified.
确定常规口服和肠内营养补充是否能改善成年患者的体重、人体测量指标及生存率。
对成人口服或肠内蛋白质补充的随机对照试验进行系统评价。从医学文献数据库(银盘3.11,1966 - 1996年)、已识别研究和综述文章的参考文献列表以及与饲料制造商的交流中识别试验。
比较口服或肠内蛋白质补充与无常规补充的随机对照试验。纳入所有成年受试者的试验,但不包括涉及孕期营养的试验。
体重和人体测量指标(上臂肌肉周长)的变化,以及在预定随访结束时记录的全因病死率。体重和人体测量指标分析为这些变量变化百分比的加权平均差和95%置信区间。病死率分析采用比值比和95%置信区间。
确定了1979年2月至1996年7月发表的32篇合格报告(2286例随机分组患者),其中30篇(93.8%)(2062例随机分组患者)报告了感兴趣的结果。1670例(81%)患者有病死率数据,1607例(78%)患者有连续变量数据。与对照组相比,接受常规营养补充的治疗组体重和人体测量指标持续改善;加权平均差分别为2.06%(95%置信区间1.63%至2.49%)和3.16%(2.43%至3.89%)。治疗组死亡的合并比值比为0.66(0.48至0.91,P<0.01)。在几个预先指定的患者亚组、治疗环境和干预措施中观察到明显益处,但如果排除方法学不太可靠的试验则不明显。
常规口服或肠内补充似乎能改善成年患者的营养指标,但在符合严格方法学标准的试验中,数据不足以确定是否降低了死亡率。益处不限于特定患者群体。进一步开展常规营养补充的大型实用随机对照试验是合理的。